Abiopharma

Clinical trial NCT05215106 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-01 → 2026-09-15 3. primary completion date: 2026-06-01 → 2026-08-15

Clinical trial NCT06714864 updates: 1. completion date: 2026-03-01 → 2029-04-01 2. primary completion date: 2026-01-01 → 2028-07-01

Clinical trial NCT06442436: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07600983: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT06412120 updates: 1. start date: 2026-06-08 → 2026-07-28 2. completion date: 2031-06-08 → 2031-07-28 3. primary completion date: 2029-06-08 → 2029-07-28

Clinical trial NCT06703398 updates: 1. completion date: 2026-12-20 → 2027-12-20 2. primary completion date: 2026-07-10 → 2026-05-12

Clinical trial NCT07383766 updates: 1. status: RECRUITING → COMPLETED 2. start date: 2026-02-25 → 2026-03-14 3. completion date: 2027-03-25 → 2026-08-04 4. primary completion date: 2027-02-25 → 2026-06-04 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07549490: start date: 2026-08-07 → 2026-08-10.

Clinical trial NCT07017777 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05210803 updates: 1. phase: not set → PHASE2 2. completion date: 2028-03-01 → 2031-07-01 3. primary completion date: 2028-03-01 → 2031-07-01 4. enrollment: 115 → 116 participants 5. study type: OBSERVATIONAL → INTERVENTIONAL 6. allocation: not set → NON_RANDOMIZED 7. intervention model: not set → PARALLEL 8. primary …

Clinical trial NCT06800196 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-03-31 → 2025-04-10

Clinical trial NCT07648641: start date: 2026-07-01 → 2026-09-01.

Clinical trial NCT06816108 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 60 → 35 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT00911560 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-05-01 → 2026-08-03 3. primary completion date: 2027-05-01 → 2026-08-03

Clinical trial NCT07153146 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-15 → 2026-07-29 3. primary completion date: 2026-06-15 → 2026-07-29 4. enrollment: 142 → 146 participants 5. enrollment type: ESTIMATED → ACTUAL